210 related articles for article (PubMed ID: 18700564)
1. [Medical economics of hypertension therapy].
Yamazaki T
Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
[No Abstract] [Full Text] [Related]
2. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G; Delporte JP
Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
[TBL] [Abstract][Full Text] [Related]
3. Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
Wilson TW; Chockalingam A; Quest DW
J Hum Hypertens; 1996 Feb; 10 Suppl 2():S19-22. PubMed ID: 8868039
[TBL] [Abstract][Full Text] [Related]
4. [Medical economics of antihypertensive agents].
Yamazaki T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():285-8. PubMed ID: 16981557
[No Abstract] [Full Text] [Related]
5. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
Caro JJ; Lee K
Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167
[No Abstract] [Full Text] [Related]
6. Differences in medical expenditure according to drug prices.
Ueshima H
Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
[No Abstract] [Full Text] [Related]
7. [Pharmacotherapy of hypertension. How much can safely be saved?].
Anlauf M
MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
[No Abstract] [Full Text] [Related]
8. Health economic issues and the future treatment and management of hypertension.
Giles TD
AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
[No Abstract] [Full Text] [Related]
9. Oil and water? Economic advantage and biomedical progress do not mix well in a government guidelines committee.
Ménard J
Am J Hypertens; 1994 Oct; 7(10 Pt 1):877-85. PubMed ID: 7826550
[TBL] [Abstract][Full Text] [Related]
10. Hypertension, a health economics perspective.
Alcocer L; Cueto L
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):147-55. PubMed ID: 19124418
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacoeconomic assessment of antihypertensive therapy for patients of elderly and senile age in the hospital for veterans of war].
Hrinenko IuO; Kuprash LP
Lik Sprava; 2010; (3-4):108-16. PubMed ID: 21265129
[TBL] [Abstract][Full Text] [Related]
12. Drug expenditures for hypertension: an empirical test of an economic model in a French population.
Huttin C; Avorn J
Cah Sociol Demogr Med; 1997; 37(1):33-52. PubMed ID: 9239318
[No Abstract] [Full Text] [Related]
13. Out-of-pocket costs to users: medicine options for hypertension.
Arredondo A
Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
[No Abstract] [Full Text] [Related]
14. Angiotensin receptor blockers: impact on costs of care.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacoeconomic analysis of antihypertensive therapy: advantages of fixed combinations].
Leonova MV; Erofeeva SB; Bykov AV; Belousov IuB
Kardiologiia; 2008; 48(1):43-50. PubMed ID: 18260995
[No Abstract] [Full Text] [Related]
16. [Therapy of hypertension 1996. Effectiveness, tolerance, cost-benefit aspects].
Rahn KH
Med Klin (Munich); 1996 Jun; 91(6):380-3. PubMed ID: 8767312
[No Abstract] [Full Text] [Related]
17. [Fully possible to reduce the costs of hypertension treatment].
Wettermark B; Angman A; Hjemdahl P
Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
[No Abstract] [Full Text] [Related]
18. [Antihypertensive treatment. Benefits and costs].
Jensen HA; Svendsen TL
Ugeskr Laeger; 1993 Jan; 155(2):118-20. PubMed ID: 8421861
[No Abstract] [Full Text] [Related]
19. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
[No Abstract] [Full Text] [Related]
20. Cost-effective therapy for hypertension.
Barrie W
West J Med; 1996 Apr; 164(4):303-9. PubMed ID: 8732729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
